Narayana Hrudayalaya Ltd. (IN:NH)
:NH
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,380.05 - ₹2,371.60
Previous CloseN/A
Volume860.19K
Average Volume (3M)80.08K
Market Cap
₹332.16B
Enterprise Value₹355.50B
Total Cash (Recent Filing)₹18.24B
Total Debt (Recent Filing)₹23.40B
Price to Earnings (P/E)75.8
Beta0.80
Next Earnings
May 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)6.30
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio92.72
Price to Book (P/B)9.40
Price to Sales (P/S)6.22
P/FCF Ratio-354.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,130.00Price Target Upside21.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)43.02
Revenue Forecast (FY)₹77.94B
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendConsistent revenue growth—more than doubling from 2021 to 2025—reflects durable expansion in patient volumes, case mix and network scale across tertiary specialties. This secular top‑line momentum supports sustained investment capacity and resilience over the next 2–6 months.
Operating Cash Flow StrengthStable, positive operating cash flows and efficient conversion of income into cash show the business reliably turns earnings into liquidity. That capability funds working capital and capital expenditure, reduces reliance on external funding, and supports medium‑term operational continuity.
Healthy Balance Sheet / Equity PositionA solid equity base and manageable leverage provide financial flexibility to invest in new facilities and absorb demand shocks. Prudent balance‑sheet metrics enable capital allocation for strategic growth while preserving the ability to negotiate supplier and financing terms over the medium term.
Bears Say
Rising Total DebtAn upward trend in total debt increases leverage and interest cost exposure. If debt accumulation continues, it can constrain capital allocation, elevate refinancing risk and limit strategic flexibility—issues that materially affect financial robustness over a 2–6 month horizon.
Negative Free Cash Flow In 2025A move to negative free cash flow driven by elevated capex signals near‑term cash strain. If higher investment persists, the company may need additional financing or to reallocate resources, which could pressure liquidity and slow discretionary initiatives over the medium term.
Declining EBITDA MarginA declining EBITDA margin points to rising input costs or margin dilution from growth investments. Sustained margin erosion would reduce operating profitability and internal cash generation, weakening the structural advantage of scale and potentially raising funding needs.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1380.05 and its highest was ₹2371.60 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹332.16B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is May 15, 2026 which is in 50 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on Feb 13, 2026. The company reported ₹6.3 earnings per share for the quarter, missing the consensus estimate of ₹11.8 by -₹5.5.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Undervalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.24%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹6.3 in its last earnings report, missing expectations of ₹11.8. Following the earnings report the stock price went down -2.307%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
NH Stock 12 Month Forecast
Average Price Target
₹2,130.00
▲(21.27% Upside)
Technical Analysis
Aurobindo Pharma Ltd
―
Fortis Healthcare Ltd.
―
HealthCare Global Enterprises Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Global Health Limited
―